These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy. Gao J; Zhao L; Wan YY; Zhu B Int J Mol Sci; 2015 May; 16(5):10267-80. PubMed ID: 25955647 [TBL] [Abstract][Full Text] [Related]
4. The IL-2 cytokine family in cancer immunotherapy. Sim GC; Radvanyi L Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249 [TBL] [Abstract][Full Text] [Related]
5. Prospect of IL-2, IL-7, IL-15 and IL-21 for HIV immune-based therapy. Diallo M; Zheng Y; Chen X; He Y; Zhou H; Chen Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1037-45. PubMed ID: 22169717 [TBL] [Abstract][Full Text] [Related]
6. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients. Rosenthal R; Groeper C; Bracci L; Adamina M; Feder-Mengus C; Zajac P; Iezzi G; Bolli M; Weber WP; Frey DM; von Holzen U; Oertli D; Heberer M; Spagnoli GC J Immunother; 2009 Apr; 32(3):252-61. PubMed ID: 19242375 [TBL] [Abstract][Full Text] [Related]
7. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy. Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Tahara H; Lotze MT Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935 [TBL] [Abstract][Full Text] [Related]
9. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. O'Malley BW; Li D; McQuone SJ; Ralston R Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy. Maccalli C; Parmiani G; Ferrone S Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848 [TBL] [Abstract][Full Text] [Related]
11. Common gamma chain cytokines in combinatorial immune strategies against cancer. Pulliam SR; Uzhachenko RV; Adunyah SE; Shanker A Immunol Lett; 2016 Jan; 169():61-72. PubMed ID: 26597610 [TBL] [Abstract][Full Text] [Related]
12. The role of cytokines in T-cell memory in health and disease. Raeber ME; Zurbuchen Y; Impellizzieri D; Boyman O Immunol Rev; 2018 May; 283(1):176-193. PubMed ID: 29664568 [TBL] [Abstract][Full Text] [Related]
14. The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy. Wang C; Kong L; Kim S; Lee S; Oh S; Jo S; Jang I; Kim TD Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142322 [TBL] [Abstract][Full Text] [Related]
15. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy. von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403 [TBL] [Abstract][Full Text] [Related]